Author:
O’Donnell Robert T.,Ma Yunpeng,McKnight Hayes C.,Pearson David,Tuscano Joseph M.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference24 articles.
1. Molina A (2008) A decade of rituximab: improving survival outcomes in non-Hodgkin’s lymphoma. Ann Rev Med 59:237–250
2. Sato S, Tuscano JM, Inaoki M, Tedder TF (1998) CD22 negatively, positively regulates signal transduction through the B lymphocyte antigen receptor. Semin Immunol 10(4):287–297
3. Williamson JM, Grigor I, Smith ME et al (1987) Ploidy, proliferative activity, cluster differentiation antigen expression, clinical remission in high-grade non-Hodgkin’s lymphoma. Histopathology 11(10):1043–1054
4. Law CL, Aruffo A, Chandran KA, Doty RT (1995) Ig domains 1, 2 of murine CD22 constitute the ligand-binding domain, bind multiple sialylated ligands expressed on B, T cells. J Immunol 155(7):3368–3376
5. Tedder TF, Tuscano J, Sato S, Kehrl JH (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol 15:481–504
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献